Survey of the state of the art in biomaterials, cells, genes and proteins integrated into micro- and nanoscaffolds for tissue regeneration

Current Nanoscience

Volumn 5, Issue 2, 2009, Pages 189-203

  Marimuthu, Mohana ^a   Kim, Sanghyo ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

Biomaterial; Cell; Gene; Growth factor; Micro and nanoscaffold; Tissue regeneration

Indexed keywords

ACTIVE BIOMOLECULES; CARRIER SYSTEMS; CELL CARRIER; CELL TYPES; EXCITING FIELD; GROWTH FACTOR; MATRIX; MICRO- AND NANOSCAFFOLD; NANOCOMPOSITE MATERIALS; NANOSCAFFOLDS; NANOSCIENCE AND NANOTECHNOLOGIES; REGENERATIVE MEDICINE; SEQUENTIAL DELIVERY; STATE OF THE ART; SYNTHETIC POLYMERS; TISSUE REGENERATION; TISSUE REPAIR;

BIOACTIVITY; BIOMATERIALS; BIOMOLECULES; GROWTH (MATERIALS); NANOCOMPOSITES; NANOSCIENCE; NATURAL POLYMERS; PEPTIDES;

TISSUE;

ALGINIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; COLLAGEN; DEXAMETHASONE; FIBRIN; GENTAMICIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GROWTH FACTOR; HYALURONIC ACID; INSULIN; INTERLEUKIN 12; MOLECULAR SCAFFOLD; NAKED DNA; NANOCOMPOSITE; NEUROTROPHIN 3; PLASMID DNA; PLASMIN; POLYAMIDOAMINE; POLYETHYLENEIMINE; POLYMER; POLYSACCHARIDE; PROTEIN; SILK FIBROIN; STARCH; TRANSFORMING GROWTH FACTOR BETA1; UNINDEXED DRUG; VASCULOTROPIN;

ANGIOGENESIS; BONE REGENERATION; CARTILAGE; CELL TYPE; CHRONIC INFLAMMATION; DEGENERATIVE DISEASE; DRUG DELIVERY SYSTEM; ENCAPSULATION; GENE TARGETING; GENE TRANSFER; HUMAN; NANOTECHNOLOGY; NERVE REGENERATION; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SKIN; SOLID TUMOR; TISSUE ENGINEERING; TISSUE REGENERATION; TOOTH;

EID: 70350647481     PISSN: 15734137     EISSN: None     Source Type: Journal    
DOI: 10.2174/157341309788185389     Document Type: Review

References (215)

1. Sokolsky-Papkov, M.; Agashi, K.; Olaye, A.; Shakesheff, K.; Domb, AJ. Polymer carriers for drug delivery in tissue engineering. Adv. Drug Deliv. Rev., 2007, 59, 187-206. (Pubitemid 46887622)
2. Fabiana, Q. Bioinspired tissue engineering: The great promise of protein delivery technologies. Int. J. Pharm., 2008, 364, 281-297.
3. Anjana, J.; Young-Tae, K.; Robert, J.M.; Ravi, V.B. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials, 2006, 27, 497-504.
4. Hockin, H.K.X.; Michael, D.W.; Carl, G.S. Injectable and strong nanoapatite scaffolds for cell/growth factor delivery and bone regeneration. Dent. Mater., 2008, 24, 1212-1222.
5. Kuniko, H.; Chie, S.; Junji, H.; Kenta, Y.; Yu, K.; Makoto, O.; Yasuhiko, T.; Shigeru, K. Controlled-release of epidermal growth factor from cationized gelatin hydrogel enhances corneal epithelial wound healing. J. Control. Release, 2007, 118, 169-176. (Pubitemid 46329733)
6. Vehof, J.W.M.; Fisher, J.P.; Dean, D.; Van der Waerden, J.P.C.M.; Spauwen, P.H.M.; Mikos, AG.; Jansen, J. Bone formation in transforming growth factor β-1-coated porous poly (propylene fumarate) scaffolds. J. Biomed. Mater. Res., 2002, 60, 241-251. (Pubitemid 34194585)
7. Henning, S.; Herbert, A.W.; Christian, D.; Rudolf, G.; Sarah, F. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid - An experimental study in rats. Biomaterials, 2008, 29, 103-110.
8. Sheridan, M.H.; Shea, L.D.; Peters, M.C.; Mooney, D.J. Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J. Control. Release, 2000, 63, 91-102.
9. Yoon, J.J.; Kim, J.H.; Park, T.G. Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method. Biomaterials, 2003, 23, 2323-2329.
10. Zhang, G.; Suggs, L.J. Matrices and scaffolds for drug delivery in vascular tissue engineering. Adv. Drug Deliv.Rev., 2007, 59, 360-373. (Pubitemid 46879974)
11. Moioli, E.K.; Clark, P.A.; Xin, X.; Lal, S.; Mao, J.J. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv. Drug Deliv.Rev., 2007, 59, 308-324. (Pubitemid 46887621)
12. Domb, A.; Mikos, A.G. Matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev., 2007, 59, 185-186. (Pubitemid 46879976)
13. Malafaya, P.B.; Silva, G.A.; Reis, R.L. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev., 2007, 59, 207-233.
14. Biondi, M.; Ungaro, F.; Quaglia, F.; Netti, P.A. Controlled drug delivery in tissue engineering. Adv. Drug Deliv. Rev., 2008, 60, 229-242.
15. Pek, Y.S.; Shujun, G.; Mohamed Arshad, M.S.; Kwong-Joo, L.; Jackie, Y.Y. Porous collagen-apatite nanocomposite foams as bone regeneration scaffolds. Biomaterials, 2008, 29, 4300-4305.
16. Zeugolis, D.I.; Paul, R.G.; Attenburrow, G. Post-self-assembly experimentation on extruded collagen fibres for tissue engineering applications. Acta Biomater., 2008, 4, 1646-1656. (Pubitemid 351611626)
17. Yowa, S.Z.; Quek, C.H.; Yim, E.K.F.; Lim, C.T.; Leong, K.W. Collagen-based fibrous scaffold for spatial organization of encapsulated and seeded human mesenchymal stem cells. Biomaterials, doi:10.1016/j.biomaterials. 2008.11.003.
18. Chevallay, B.; Herbage, D. Collagen-based biomaterials as 3D scaffolds for cell cultures: application for tissue engineering and gene therapy. Med. Biol. Eng. Comput., 2000, 38, 211-218. (Pubitemid 30192997)
19. Young, S.; Wong, M.; Tabata, Y.; Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release, 2005, 109, 256-274.
20. Sha, H.; Yijuan, W.; Tang, L.; Fang, J.; Shouxin, L.; Yan, J. Fabrication and characterization of a novel microparticle with gyrus-patterned surface and growth factor delivery for cartilage tissue engineering. Mat. Sci. Eng. C., doi:10.1016/j.msec.2008.10.036.
21. Zarana, S.P.; Simon, Y.; Yasuhiko, T.; John, A.J.; Mark, E.K.W.; Antonios, G.M. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone, 2008, 43, 931-940.
22. Hino, R.; Tomito, M.; Yoshizato, K. The generation of germ line transgenic silkworms for the production of biologically active recombinant fusion proteins of fibroin and human basic fibroblast growth factor. Biomaterials, 2006, 27, 5715-5724. (Pubitemid 44279069)
23. Daqing, H.; Weiqiang, L.; Qiang, A.; Guangzhi, W. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin incorporated fibrin-fibronectin matrix. Med. Hypotheses, 2008, 71, 374-378.
24. Swierczewska, M.; Hajicharalambous, C.S.; Janorkar, A.V.; Megeed, Z.; Yarmush, M.L.; Rajagopalan, P. Cellular response to nanoscale elastin-like polypeptide polyelectrolyte multilayers. Acta Biomater., 2008, 4, 827-837. (Pubitemid 351753681)
25. Betre, H.; Ong, S.R.; Guilak, F.; Chilkoti, A.; Fermor, B.; Setton, L.A. Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials, 2006, 27, 91-99. (Pubitemid 41225372)
26. Yi, H.S.; Molly, S.S.; Milica, R. Vascular endothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater., 2008, 4, 477-489.
27. Xu, X.L.; Lou, J.; Tang TT.; Ng, K.W.; Zhang, J.H.; Yu, C.; Dai, K. Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. J. Biomed. Mater. Res. B Appl. Biomater., 2005, 75B, 289-303. (Pubitemid 41609549)
28. Ren, L.; Osaka, A.; Yu, B.; Shi, W.; Ge, D.T.; Chen, S. Bioactive gelatin-siloxane hybrids as tissue engineering scaffolds. In Solid State Phenomena: Science and Technology Hybrid Materials; Sun, C.J.; Ding, J.; Gupta, M.; Chow, G.M.; Kurihara, L.; Kabacoff, L., Eds.; Trans Tech Publications: Switzerland, 2006, pp. 13-18. (Pubitemid 47544813)
29. Awad, H.A.; Quinn, W.M.; Leddy, H.A.; Gimble, J.M.; Guilak, F. Chondrogenic differentiation of adipose - derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 2004, 25, 3211-3222. (Pubitemid 38234782)
30. Zarana, S.P.; Masaya, Y.; Hiroki, U.; Yasuhiko, T.; Antonios, G.M. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater, 2008, 4, 1126-1138.
31. Kimura, Y.; Ozeki, M.; Inamoto, T.; Tabata, Y. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials, 2003, 24, 2513-2521. (Pubitemid 36407668)
32. Li, C.; Vepari, C.; Jin, H.J.; Kim, H.J.; Kaplan, D.L. Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials, 2006, 27, 3115-3124. (Pubitemid 43247585)
33. Ehrbar, M.; Metters, A.; Zammaretti, P.; Hubbell, J.A.; Zisch, A.H. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. J. Control. Release, 2005, 101, 93-109.
34. Jeon, O.; Kang, S.W.; Lim, H.W.; Chung, J.; Kim, B.S. Long-term and zeroorder release of basic fibroblast growth factor from heparin conjugated poly (l-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials, 2006, 27, 1598-1607.
35. Neidert, M.R.; Lee, E.S.; Oegema, T.R.; Tranquillo, R.T. Enhanced fibrin remodeling in vitro with TGF-beta1, insulin and plasmin for improved tissue-equivalents. Biomaterials, 2002, 23, 3717-3731.
36. Taylor, S.J.; Rosenzweig, E.S.; McDonald III, J.W.; Sakiyama-Elbert, S.E. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J. Control. Release, 2006, 113, 226-235. (Pubitemid 43963190)
37. Taylor, S.J.; Sakiyama-Elbert, S.E. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J. Control. Release, 2006, 116, 204-210. (Pubitemid 44854282)
38. Khor, E.; Lim, L.Y. Implantable applications of chitin and chitosan. Biomaterials, 2003, 24, 2339-2349.
39. Di Martino, A.; Sittinger, M.; Risbud, M.V. Chitosan: a versatile biopolymer for orthopaedic tissue-engineering. Biomaterials, 2005, 26, 5983-5990.
40. Kweon, D.K.; Song, S.B.; Park, Y.Y. Preparation of water-soluble chitosan/heparin complex and its application as wound healing accelerator. Biomaterials, 2003, 24, 1595-1601.
41. Jiankang, H.; Dichen, L.; Yaxiong, L.; Bo, Y.; Hanxiang, Z.; Qin, L.; Bingheng, L.; Yi, L. Preparation of chitosan-gelatin hybrid scaffolds with well-organized microstructures for hepatic tissue engineering. Acta Biomater., 2009, 5, 453-461.
42. Duarte, A.R.C.; Mano, J.F.; Reis, R.L. Preparation of chitosan scaffolds loaded with dexamethasone for tissue engineering applications using supercritical fluid technology. Eur. Polym. J., 2009, 45(1), 141-148.
43. Salgado, A.J.; Coutinho, O.P.; Reis, R.L.; Davies, J.E. In vivo response to starch-based scaffolds designed for bone tissue engineering applications. J. Biomed. Mater. Res. A, 2007, 80A, 983-989. (Pubitemid 46310002)
44. Santos, M.I.; Tuzlakoglu, K.; Fuchs, S.; Gomes, M.E.; Peters, K.; Unger, R.E.; Piskin, E.; Reis, R.L.; Kirkpatrick, C.J. Endothelial cell colonization and angiogenic potential of combined nano- and micro-fibrous scaffolds for bone tissue engineering. Biomaterials, 2008, 29, 4306-4313.
45. Ghosh, S.; Viana, J.C.; Reis, R.L.; Mano, J.F. Bi-layered constructs based on poly(L-lactic acid) and starch for tissue engineering of osteochondral defects. Mater. Sci. Eng., C, 2008, 28, 80-86.
46. Sundaram, J.; Durance, T.D.; Wang, R. Porous scaffold of gelatin-starch with nanohydroxyapatite composite processed via novel microwave vacuum drying. Acta Biomater, 2008, 4, 932-942.
47. Martins, A.M.; Santos, M.I.; Azevedo, H.S.; Malafaya, P.B.; Reis, R.L. Natural origin scaffolds with in situ pore forming capability for bone tissue engineering applications. Acta Biomater., 2008, 4, 1637-1645.
48. Yu, J.; Gu, Y.; Du, K.T.; Mihardja, S. The effect of injected RGD modified alginate on angiogenesis and left ventricular function in a chronic rat infarct model. Biomaterials, doi:10.1016/j.biomaterials.2008.09.059.
49. Scuderi, N.; Onesti, M.G.; Bistoni, G.; Ceccarelli, S.; Rotolo, S.; Angeloni, A.; Marchese, C. The clinical application of autologous bioengineered skin based on a hyaluronic acid scaffold. Biomaterials, 2008, 29, 1620-1629.
50. Pek, Y.S.; Kurisawa, M.; Gao, S.; Chung, J.E.; Ying, J.Y. The development of a nanocrystalline apatite reinforced crosslinked hyaluronic acid-tyramine composite as an injectable bone cement, Biomaterials, doi:10.1016/j. biomaterials.2008.10.053.
51. Park, Y.J.; Lee, Y.M.; Lee, J.Y.; Seol, Y.J.; Chung, C.P.; Lee, S.J. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate- chitosan sponge for guided bone regeneration. J. Control. Release, 2000, 67, 385-394.
52. Holmbom, J.; Ekholm, E.; Martson, M.; Liiho, M.; Salonen, J.; Penttinen, R. Cellulose and bioactive glass in bone tissue engineering. Bone, 2002, 30, 5S-8S.
53. Muller, F.A.; Muller, L.; Hofmann, I.; Greil, P.; Wenzel, M.M.; Staudenmaier, R. Cellulose-based scaffold materials for cartilage tissue engineering. Biomaterials, 2006, 27, 3955-3963. (Pubitemid 44316595)
54. Entcheva, E.; Bien, H.; Yin, L.H.; Chung, C.Y.; Farrell, M.; Kostov, Y. Functional cardiac cell constructs on cellulose-based scaffolding. Biomaterials, 2004, 25, 5753-5762. (Pubitemid 38624455)
55. Chen, G.Q.; Wu, Q. The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials, 2005, 26, 6565-6578. (Pubitemid 41021750)
56. Zhang, Y.; Cheng, X.; Wang, J.; Wang, Y.; Shi, B.; Huang, C.; Yang, X.; Liu, T. Novel chitosan/collagen scaffold containing transforming growth factor-beta1 DNA for periodontal tissue engineering. Biochem. Biophys. Res. Commun., 2006, 344, 362-369. (Pubitemid 44113906)
57. Goraltchouk, A.; Scanga, V.; Morshead, C.M.; Shoichet, M.S. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J. Control. Release, 2006, 110, 400-407.
58. Gomes, M.E.; Ribeiro, A.S.; Malafaya, P.B.; Reis, R.L.; Cunha, A.M. A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. Biomaterials, 2001, 22, 883-889.
59. Malafaya, P.B.; Stappers, F.; Reis, R.L. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers. J. Mater. Sci. Mater. Med., 2006, 17, 371-377.
60. Grunder, T.; Gaissmaier, C.; Fritz, J.; Stoop, R.; Hortschansky, P.; Mollenhauer, J. Bone morphogenetic protein-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage, 2004, 12, 559-567. (Pubitemid 38950266)
61. Heywood, H.K.; Bader, D.L.; Lee, D.A. Glucose concentration and medium volume influence cell viability and glycosaminoglycan synthesis in Chondrocyte-seeded alginate constructs. Tissue Eng., 2006, 12, 3487-3496.
62. Yun, Y.H.; Goetz, D.J.; Yellen, P.; Chen, W.L. Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials, 2004, 25, 147-157.
63. Park, Y.J.; Lee, Y.M.; Lee, J.Y.; Seol, Y.J.; Chung, C.P.; Lee, S.J. Controlled release of platelet-derived growth factor-BB from chondroitin sulfate-chitosan sponge for guided bone regeneration. J. Control. Release, 2000, 67, 385-394.
64. Liu, Y.; Yang, H.; Otaka, K.; Takatsuki, H.; Sakanishi, A. Effects of vascular endothelial growth factor (VEGF) and chondroitin sulfate A on human monocytic THP-1 cell migration. Colloids Surf. B, 2005, 43, 216-220. (Pubitemid 40909845)
65. Levesque, S.G.; Shoichet, M.S. Synthesis of cell-adhesive dextran hydrogels and macroporous scaffolds. Biomaterials, 2006, 27, 5277-5285. (Pubitemid 44080307)
66. Stevens, M.M.; Marini, R.P.; Martin, I.; Langer, R.; Shastri, V.P. FGF-2 enhances TGF-beta1-induced periosteal chondrogenesis. J. Orthop. Res., 2004, 22, 1114-1119.
67. Bloch, K.; Lozinsky, V.I.; Galaev, I.Y.; Yavriyanz, K.; Vorobeychik, M.; Azarov, D. Functional activity of insulinoma cells (INS-1E) and pancreatic islets cultured in agarose cryogel sponges. J. Biomed. Mater. Res. A, 2005, 75 A, 802-809. (Pubitemid 41772698)
68. Jiang, W.G.; Harding, K.G. Enhancement of wound tissue expansion and angiogenesis by matrix-embedded fibroblast (Dermagraft), a role of hepatocyte growth factor scatter factor. Int. J. Mol. Med., 1998, 2, 203-210.
69. Jose, M.V.; Thomas, V.; Johnson, K.T.; Dean, D.R.; Nyairo, E. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater., 2009, 5, 305-315.
70. Wang, M.; Chen, W.; Zhang, H.; Li, X.; Zhang, Y.; Yao, K.; Yao, F. Synthesis and characterization of PLLA-PLCA-PEG multiblock copolymers and their applications in modifying PLLA porous scaffolds. Eur. Polym. J., 2007, 43, 4683-4694.
71. Clapper, J.D.; Skeie, J.M.; Mullins, R.F.; Guymon, A. Development and characterization of photopolymerizable biodegradable materials from PEGe-PLAePEG block macromonomers. Polymer, 2007, 48, 6554-6564.
72. Shah, N.M.; Pool, M.D.; Metters, A.T. Influence of network structure on the degradation of photo-cross-linked PLA-b-PEG-b-PLA hydrogels. Biomacromolecules, 2006, 7, 3171-3177.
73. Zhu, Y.B.; Chan-Park, B.; Chian, K.S. The growth improvement of porcine esophageal smooth muscle cells on collagen-grafted poly (DL-lactide-co glycolide) membrane. J. Biomed. Mater. Res. B Appl. Biomater., 2005, 75b, 193-199.
74. He, S.L.; Yaszemski, M.J.; Yasko, A.W.; Engel, P.S.; Mikos, A.G. Injectable biodegradable polymer composites based on poly (propylene fumarate) crosslinked with poly (ethylene glycol)-dimethacrylate. Biomaterials, 2000, 21, 2389-2394.
75. Jabbari, E.; Wang, S.F.; Lu, L.C.; Gruetzmacher, J.A.; Ameenuddin, S.; Hefferan, T.E.; Bradford, C.; Anthony, W.; Michael, Y. Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly (caprolactone fumarate) as an injectable tissue engineering scaffold. Biomacromolecules, 2005, 6, 2503-2511.
76. Moroni, L.; Licht, R.; Boer, J.D.; Wijn, J.R.D.; Blitterswijk, C.A.W. Fiber diameter and texture of electrospun PEOT/PBT scaffolds influence human mesenchymal stem cell proliferation and morphology, and the release of incorporated compounds. Biomaterials, 2006, 27, 4911-4922.
77. Maldaa, J.; Woodfielda, T.B.F.; Vloodta, V.D.; Wilsond, C.; Martensc, D.E.; Tramperc, J.; Blitterswijka, C.A.V.; Riesle, J. The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials, 2005, 26, 63-72. (Pubitemid 38759472)
78. Ferruti, P.; Bianchi, S.; Ranucci, E.; Chiellini, F.; Caruso, V. Novel poly (amido amine)-based hydrogels as scaffolds for tissue engineering. Macromol. Biosci., 2005, 5, 613-622. (Pubitemid 41020252)
79. Bonzani, I.C.; George, J.H.; Stevens, M.M. Synthesis of two-component injectable polyurethanes for bone tissue engineering. Biomaterials, 2007, 28, 423-433.
80. Zhu, Y.; Gao, C.Y.; He, T.; Shen, J.C. Endothelium regeneration on luminal surface of polyurethane vascular scaffold modified with diamine and covalently grafted with gelatin. Biomaterials, 2004, 25, 423-430.
81. Phan, T.T. Evaluation of cell culture on the polyurethane-based membrane (Tegaderm): implication for tissue engineering of skin. Cell Tissue Bank., 2005, 6, 91-97.
82. Chia, S.L.; Gorna, K.; Godolewski, S.; Alini, M. Biodegradable elastomeric polyurethane membranes as chondrocyte carriers for cartilage repair. Tissue Eng., 2006, 12, 1945-1953. (Pubitemid 44162853)
83. Ohya, Y.; Matsunami, H.; Ouchi, T. Cell growth on the porous sponges prepared from poly (depsipeptide-co-lactide) having various functional groups. J. Biomater. Sci. Polym. Ed., 2004, 15, 111-123. (Pubitemid 38239674)
84. Martina, M.; Hutmacher, D.W. Biodegradable polymers applied in tissue engineering research: a review. Polym. Int., 2007, 56, 145-157.
85. Richardson, R.T.; Thompson, B.; Moulton, S.; Newbold, C.; Lum, M.G.; Cameron, A. The effect of Polypyrrole with incorporated neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials, 2007, 28, 513-523. (Pubitemid 44602239)
86. Jansen, J.A.; Vehof, J.W.M.; Ruhé, P.Q.; Kroeze-Deutman, H.; Kuboki, Y.; Takita, H.; Hedberg, E.L.; Mikos, A.G. Growth factor-loaded scaffolds for bone engineering. J. Control. Release, 2005, 101, 127-136. (Pubitemid 39600977)
87. Habraken, W.J.E.M.; Wolke, J.G.C.; Jansen, J.A. Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering. Adv. Drug Deliv. Rev., 2007, 59, 234-248. (Pubitemid 46879968)
88. Stallmann, H.P.; Faber, C.; Bronckers, A.L.J.J.; Nieuw Amerongen, A.V.V.; Wuisman, P.I.J.M. In vitro gentamycin release from commercially available calcium-phosphate bone substitutes influence of carrier type on duration of the release profile. BMC Musculosket. Disord., 2006, 7(18), 1-8.
89. Kimakhe, S.; Bohic, S.; Larosse, C.; Reynaud, A.; Pilet, P.; Giumelli, B.; Heymann, D.; Daculsi, G. Biological activities of sustained polymixin B release from calcium phosphate biomaterial prepared by dynamic compaction: an in vitro study. J. Biomed. Mater. Res., 1999, 47, 18-27. (Pubitemid 29344965)
90. Guicheux, J.; Gauthier, O.; Aguado, E.; Heymann, D.; Pilet, P.; Couillard, S.; Faivre, A.; Daculsi, G. Growth hormone-loaded macroporous calcium phosphate ceramic: in vitro biopharmaceutical characterization and preliminary in vivo study. J. Biomed. Mater. Res., 1998, 40, 560-566. (Pubitemid 28225841)
91. Zhang, F.; Lin, K.; Changa, J.; Lua, J.; Ning, C. Spark plasma sintering of macroporous calcium phosphate scaffolds from nanocrystalline powders. J. Eur. Ceram. Soc., 2008, 28, 539-545. (Pubitemid 350123421)
92. Valerio, P.; Pereira, M.M.; Goes, A.M.; Leite, M.F. The effect of ionic products from bioactive glass dissolution on osteoblast proliferation and collagen production. Biomaterials, 2004, 25, 2941-2948.
93. Wu, C.T.; Chang, J.; Wang, J.Y.; Ni, S.Y.; Zhai, W.Y. Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials, 2005, 26, 2925-2931.
94. 16) scaffold with biomimetic apatite layer for bone tissue engineering. J. Mater. Sci. Mater. Med., 2007, 18, 857-864.
95. 3 scaffold for bone tissue engineering. J. Biomed Mater., 2006, 76(1), 196-205.
96. Wu, C.T.; Chang, J. Synthesis and apatite-formation ability of akermanite. Mater. Lett., 2004, 58, 2415-2417.
97. Chengtie, W.; Jiang, C.; Wanyin, Z.; Siyu, N.; Junying, W. Porous Akermanite Scaffolds for Bone Tissue Engineering: Preparation, characterization, and in vitro studies. J. Biomed. Mater. Res. B Appl. Biomater., 2006, 78(1), 47-55.
98. Ruhé, P.Q.; Boerman, O.C.; Russel, F.G.M.; Mikos, A.G.; Spauwen, P.H.M.; Jansen, J.A. In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin. J. Mater. Sci. Mater. Med., 2006, 17(10), 919-927. (Pubitemid 44411286)
99. Stallmann, H.P.; Faber, C.; Slotema, E.T.; Lyaruu, D.M.; Bronckers, A.L.J.J.; Nieuw Amerongen, A.V.; Wuisman, P.I.J.M. Continuous-release or burst release of the antimicrobial peptide human lactoferrin 1-11(hLF1-11) from calcium phosphate bone substitutes. J. Antimicrob. Chemother., 2003, 52, 853-855.
100. Seeherman, H.; Li, R.; Bouxsein, M.; Kim, H.; Li, X.J.; Smith-Adaline, E.A.; Aiolova, M.; Wozney, J.M. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J. Bone Jt. Surg. Am., 2006, 88(1), 144-160.
101. Ruhé, P.Q.; Kroeze-Deutman, H.C.; Wolke, J.G.C.; Spauwen, P.H.M.; Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants in cranial defects in rabbits. Biomaterials, 2004, 25, 2123-2132. (Pubitemid 38102412)
102. Kroese-Deutman, H.C.; Ruhé, P.Q.; Spauwen, P.H.M.; Jansen, J.A. Bone inductive properties of rhBMP-2 loaded porous calcium phosphate cement implants inserted at an ectopic site in rabbits. Biomaterials, 2005, 26, 1131-1138. (Pubitemid 39286822)
103. Xua, H.H.K.; Weir, M.D.; Simon, C.G. Injectable and strong nano-apatite scaffolds for cell/growth factor delivery and bone regeneration. Dent. Mater., 2008, 24, 1212-1222.
104. Tuominen, T.; Jamsa, T.; Tuukkanen, J.; Nieminen, P.; Lindholm, T.C.; Lindholm, T.S.; Jalovaara, P. Native bovine bone morphogenetic protein improves the potential of biocoral to heal segmental canine ulnar defects. Int. Orthop., 2000, 24, 289-294.
105. Schopper, C.; Moser, D.; Sabbas, A.; Lagogiannis, G.; Spassova, E.; Konig, F.; Donath, K.; Ewers, R. The fluorohydroxyapatite (FHA) FRIOS Algipore is a suitable biomaterial for the reconstruction of severely atrophic human maxillae. Clin. Oral Implants Res., 2003, 14, 743-749.
106. Hou, R.; Chen, F.; Yang, Y.; Cheng, X.; Gao, Z.; Yang, H.O.; Wu, W.; Mao, T. Comparative study between coral-mesenchymal stem cells-rhBMP-2 composite and auto-bone-graft in rabbit critical-sized cranial defect model. J. Biomed. Mater. Res. A, 2007, 80, 85-93. (Pubitemid 44913336)
107. Zhu, Y.; Shi, J. A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug. Micropor. Mesopor. Mat., 2007, 103, 243-249. (Pubitemid 46810341)
108. Zhu, Y.; Shi, J.; Shen, W.; Chen, H.; Dong, X.; Ruan, M. Preparation of novel hollow mesoporous silica spheres and their sustained-release property. Nanotechnology, 2005, 16, 2633-2638. (Pubitemid 41436782)
109. Yun, H.; Kim, S.; Hyeon, Y. Design and preparation of bioactive glasses with hierarchical pore networks. Chem. Commun., 2007, 2139-2141.
110. Li, X.; Wang, X.; Chen, H.; Jiang, P.; Dong, X.; Shi, J. Hierarchically porous bioactive glass scaffolds synthesized with a PUF and P123 cotemplated Approach. Chem. Mater., 2007, 19, 4322-4326. (Pubitemid 47340307)
111. Yufang, Z.; Chengtie, W.; Yogambha, R.; Emanuel, K.; Paul, S.; Stefan, K.; Hala, Z. Preparation, characterization and in vitro bioactivity of mesoporous bioactive glasses (MBGs) scaffolds for bone tissue engineering. Micropor. Mesopor. Mater., 2008, 112, 494-503.
112. Domingues, Z.R.; Cortés, M.E.; Gomes, T.A.; Diniz, H.F.; Freitas, C.S.; Gomes, J.B.; Faria, A.M.C.; Sinisterra, R.D. Bioactive glass as a drug delivery system of tetracycline and tetracycline associated with β-cyclodextrin. Biomaterials, 2004, 25, 327-333. (Pubitemid 37329722)
113. Ziegler, J.; Mayr-Wohlfahrt, U.; Kessler, S.; Breitig, D.; Günther, K.P. Adsorption and release properties of growth factors from biodegradable implants. J. Biomed. Mater. Res., 2002, 59, 422-428.
114. Soriano, I.; Evora, C. Formulation of calcium phosphates /poly (D, L-lactide) blends containing gentamycin for bone implantation. J. Control. Release, 2000, 68, 121-134. (Pubitemid 30407067)
115. Yang, F.; Wolke, J.G.C.; Jansen, J.A. Biomimetic calcium phosphate coating on electrospun poly (--caprolactone) scaffolds for bone tissue engineering. Chem. Eng. J., 2008, 137, 154-161.
116. Ruhé, P.Q.; Hedberg, E.L.; Torio Padron, N.; Spauwen, P.H.M.; Jansen, J.A.; Mikos, A.G. rhBMP-2 release from injectable poly(DL-lactic- coglycolic acid)/calcium phosphate cement composites. J. Bone Jt. Surg. Am., 2003, 85A(3), 75-81.
117. Lode, A.; Wolf-Brandstetter, C.; Reinstorf, A.; Bernhardt, A.; König, U.; Pompe, W.; Gelinsky, M. Calcium phosphate bones cements, functionalized with VEGF: Release kinetics and biological activity. J. Biomed. Mater. Res., 2007, 81A, 474-483. (Pubitemid 46668863)
118. Park, H.; Temenoff, J.S.; Tabata, Y.; Capland, A.I.; Mikos, A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials, 2007, 28, 3217-3227.
119. Wei, G.; Jin, Q.; Giannobile, W.V.; Ma, P.X. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J. Control. Release, 2006, 112, 103-110.
120. Andreopoulos, F.M.; Persaud, I. Delivery of basic fibroblast growth factor (bFGF) from photo responsive hydrogel scaffolds. Biomaterials, 2006, 27, 2468-2476. (Pubitemid 41821825)
121. Rives, C.B.; Rieux, A.D.; Zelivyanskaya, M.; Stock, S.R.; Lowe, W.L.; Shea, L.D. Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials, 2009, 30, 394-401.
122. Stauffera, W.R.; Cuia, X.T. Polypyrrole doped with 2 peptide sequences from laminin. Biomaterials, 2006, 27, 2405-2413.
123. Basmanav, F.B.; Kose, G.T.; Hasirci, V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials, 2008, 29, 4195-4204.
124. Rashid, S.T.; Salacinski, H.J.; Button, M.J.C.; Fuller, B.; Hamilton, G.; Seifalian, A.M. Cellular engineering of conduits for coronary and lower limb bypass surgery: role of cell attachment peptides and pre-conditioning in optimising smooth muscle cells (SMC) adherence to compliant poly (carbonate-urea) urethane (MyoLinke) scaffolds. Eur. J. Vasc. Endovasc. Surg., 2004, 27, 608-616.
125. Vitale-Brovarone, C.; Verne, E.; Robiglio, L.; Appendino, P.; Bassi, F.; Martinasso, G.; Muzio, G.; Canuto, R. Development of glass-ceramic scaffolds for bone tissue engineering: Characterisation, proliferation of human osteoblasts and nodule formation. Acta Biomater., 2007, 3, 199-208. (Pubitemid 46223892)
126. Rai, B.; Teoh, S.H.; Hutmacher, D.W.; Cao, T.; Ho, K.H. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2. Biomaterials, 2005, 26, 3739-3748. (Pubitemid 40038169)
127. Keshaw, H.; Forbes, A.; Day, R.M. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials, 2005, 26, 4171-4179.
128. Meinel, L.; Zoidis, E.; Zapf, J.; Hassa, P.; Hottiger, M.O.; Auer, J.A.; Schneider, R.; Gander, B.; Luginbuehl, V.; Bettschart-Wolfisberger, R.; Illi, O.E.; Merkle, H.P.; von Rechenberg, B. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone, 2003, 33, 660-672. (Pubitemid 37222393)
129. Storrie, H.; Mooney, D.J. Sustained delivery of plasmid DNA from polymeric scaffolds for tissue engineering. Adv. Drug Deliv. Rev., 2006, 58, 500-514. (Pubitemid 43928169)
130. Dang, J.M.; Leong, K.W. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev., 2006, 58, 487-499. (Pubitemid 43928168)
131. Kushibiki, T; Nakajima, N.N.; Sugai, M.; Shimizu, A.; Tabata, Y. Delivery of plasmid DNA expressing small interference RNA for TGF-beta type II receptor by cationized gelatin to prevent interstitial renal fibrosis. J. Control. Release, 2005, 105, 318-331. (Pubitemid 40941996)
132. Ishii, T.; Okahata, Y.; Sato, T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochem. Biophys. Acta, 2001, 1514, 51-64. (Pubitemid 32769928)
133. Corsi, K.; Chellat, F.; Yahia, L.; Fernandes, J.C. Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan- DNA nanoparticles. Biomaterials, 2003, 24, 1255-1264.
134. Sano, A.; Maeda, M.; Nagahara, S.; Ochiya, T.; Honma, K.; Itoh, H.; Miyata, T.; Fujioka, K. Atelocollagen for protein and gene delivery. Adv. Drug Deliv. Rev., 2003, 55, 1651-1677.
135. Wang, J.; Lee, I.L.; Lim, W.S.; Chia, S.M.; Yu, H.; Leong, K.W.; Mao, H. Evaluation of collagen and methylated collagen as gene carriers. Int. J. Pharm., 2004, 279, 115-126. (Pubitemid 38968647)
136. Barquinero, J.; Eixarch, H.; Perez-Melgosa, M. Retroviral vectors: new applications for an old tool. Gene Ther., 2004, 1, S3-S9. (Pubitemid 39359441)
137. Breen, A.M.; Dockery, P.; O'Brien, T.; Pandit, A.S. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. Biomaterials, 2008, 29, 3143-3151.
138. Pun, S.H.; Bellocq, N.C.; Liu, A.; Jensen, G.; Machemer, T.; Quijano, E.; Schluep, T.; Wen, S.; Engler, H.; Heidel, J.; Davis, M.E. Cyclodextrin-modified polyethylenimine polymers for gene delivery. Bioconjug. Chem., 2004, 15, 831-840. (Pubitemid 38981958)
139. Petersen, H.; Fechner, P.M.; Martin, A.L.; Kunath, K.; Stolnik, S.; Roberts, C.J.; Fischer, D.; Davies, M.C.; Kissel, T. Polyethylenimine-graft-poly (ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug, Chem., 2002, 13, 845-854.
140. Shi, L.; Tang, G.P.; Gao, S.J.; Ma, Y.X.; Liu, B.H.; Li, Y.; Zeng, J.M.; Ng, Y.K.; Leong, K.W.; Wang, S. Repeated intrathecal administration of plasmid DNA complexed with polyethylene glycol-grafted polyethylenimine led to prolonged transgene expression in the spinal cord. Gene Ther., 2003, 10, 1179-1188. (Pubitemid 36896593)
141. Lei, Y.; Segura, T. DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells. Biomaterials, 2009, 30, 254-265.
142. Chen, H.; Chang, Y.; Chuang, C.; Lin, C.; Sung, L.; Wang, Y.; Hu, Y. The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials, 2009, 30, 674-681.
143. Laporte, L.D.; Yan, A.L.; Shea, L.D. Local gene delivery from ECM-coated
144. Burger, C.; Chu, B. Functional nanofibrous scaffolds for bone reconstruction, Colloids Surf., B, 2007, 56, 134-141. (Pubitemid 46467300)
145. Lim, Y.B.; Kim, C.H.; Kim, K.; Kim, S.W.; Park, J.S. Developement of a safe gene delivery system using biodegradable polymer, poly [alpha-(4- aminobutyl)-l-glycolic acid]. J. Am. Chem. Soc., 2000, 122, 6524-6525.
146. Maheshwari, A.; Han, S.; Mahato, R.I.; Kim, S.W. Biodegradable polymer-based interleukin-12 gene delivery: role of induced cytokines, tumor infiltrating cells and nitric oxide in anti-tumor activity. Gene Ther., 2002, 9, 1075-1084.
147. Wang, J.; Mao, H.Q.; Leong, K.W. A novel biodegradable gene carrier based on poly phosphoester. J. Am. Chem. Soc., 2001, 123, 9480-9481.
148. Arigita, C.; Zuidam, N.J.; Crommelin, D.J.; Hennink, W.E. Association and dissociation characteristics of polymer/DNA complexes used for gene delivery. Pharm. Res., 1999, 16, 1534-1541. (Pubitemid 29510549)
149. Mumper, R.J.; Duguid, J.G.; Anwer, K.; Barron, M.K.; Nitta, H.; Rolland, A.P. Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm. Res., 1996, 13, 701-709.
150. Park, T.G.; Jeong, J.H.; Kim, S.W. Current status of polymeric gene delivery systems. Adv. Drug. Deliv. Rev., 2006, 58, 467-486. (Pubitemid 43949425)
151. Nie, H.; Wang, C. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J. Control. Release, 2007, 120, 111-121.
152. Ko, H.; Sfeir, C.; Kumta, P.N. In situ synthesis and characterization of porous polymer-ceramic composites as scaffolds for gene delivery. Mater. Sci. Eng. C, 2007, 27, 479-483.
153. Zhang, Y.; Wang, Y.; Shi, B.; Cheng, X. A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. Biomaterials, 2007, 28, 1515-1522. (Pubitemid 46027254)
154. O'Brien, F.J.; Harley, B.A.; Yannas, I.V.; Gibson, L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials, 2004, 25 (6), 1077-1086. (Pubitemid 37393297)
155. Juthamas, R.; Siriporn, D.; Neeracha, S.; Tanom, B.; Sorada, K. Comparison of gelatin and collagen scaffolds for fibroblast cell culture. J. Metals Mater. Minerals, 2006, 16(1), 31-36.
156. Qian, F.; Denglong, C.; Zhiming, Y.; Min, L. In vitro and in vivo research on using Antheraea pernyi silk fibroin as tissue engineering tendon scaffolds. Mater. Sci. Eng., C doi:10.1016/j.msec.2008.12.007.
157. Nihouannen, D.L.; Guehennec, L.L.; Rouillon, T.; Pilet, P.; Bilban, M.; Layrolle, P.; Daculsi, G. Micro-architecture of calcium phosphate granules and fibrin glue composites for bone tissue engineering. Biomaterials, 2006, 27, 2716-2722. (Pubitemid 43122075)
158. Sethumadhavan, S.; Theruvathil K.S.; Rangasamy, A.; Paruthapara, T.M. Hepatoprotective activity of chitosan against isoniazid and rifampicin-induced toxicity in experimental rats. Eur. J. Pharmacol., 2007, 572, 69-73. (Pubitemid 47374674)
159. Ana Rita, C. D.; João, F.M.; Rui, L.R. Preparation of starch-based scaffolds for tissue engineering by supercritical immersion precipitation. J. Supercrit. Fluid., doi:10.1016/j.supflu.2008.12.008.
160. Nishinari, K.; Takahashi, R. Interaction in polysaccharide solutions and gels. Curr. Opin. Colloid Interface Sci., 2003, 8, 396-400.
161. Liao, Y.H.; Jones, S.A.; Forbes, B.; Martin, G.P.; Brown, M.B. Hyaluronan: pharmaceutical characterization and drug delivery. Drug Deliv., 2005, 12, 327-342.
162. De Wolf, H.K.; Snel, C.J.; Verbaan, F.J.; Schiffelers, R.M.; Hennink, W.E.; Storm, G. Effect of cationic carriers on the pharmacokinetics and tumour localization of nucleic acids after intravenous administration. Int. J. Pharm., 2007, 331, 167-175. (Pubitemid 46216670)
163. Luten, J.; Van Steenbergen, M.J.; Lok, M.C.; De Graaff, A.M.; Van Nostrum, C.F.; Talsma, H.; Hennink, W.E. Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur. J. Pharm. Sci., 2008, 33(3), 241-251.
164. Ferruti, P.; Bianchi, S.; Ranucci, E.; Chiellini, F.; Caruso, V. Novel poly (amido amine)-based hydrogels as scaffolds for tissue engineering. Macromol. Biosci., 2005, 5, 613-622. (Pubitemid 41020252)
165. May P.X. Laird Forresta, M.; Giangthy, T.; Anni, Z.; Neal, M.D.; Glen, S.K. Poly(aspartate-g-PEI800), a polyethylenimine analogue of low toxicity and high transfection efficiency for gene delivery. Biomaterials, 2007, 28, 4889-4900.
166. Williams, R.L.; Krishna, Y.; Dixon, S.; Haridas, A.; Grierson, I.; Sheridan, C. Polyurethanes as potential substrates for sub-retinal retinal pigment epithelial cell transplantation. J. Mater. Sci. Mater. Med., 2005, 16, 1087-1092. (Pubitemid 41803731)
167. Link, D.P.; Van den Dolder, J.P.; Wolke, J.G.C.; Jansen, J.A. The cytocompatibility and early osteogenic characteristics of an injectable calcium phosphate cement. Tissue Eng., 2007, 13(3), 493-500. (Pubitemid 46579876)
168. Garcia, C.; Cere, S.; Duran, A. Bioactive coatings prepared by sol-gel on stainless steel 316L. J. Non-Cryst. Solid, 2004, 348, 218-224. (Pubitemid 38345868)
169. 3 powder. Mater. Res. Bull., 2009, 44, 298-305.
170. Malafayaa, P.B.; Silvaa, G.A.; Barana, E.T.; Reis, R.L. Drug delivery therapies I general trends and its importance on bone tissue engineering applications. Curr. Opin. Solid. St. M., 2002, 6, 283-295.
171. Goodman, G.R.; Dissanayake, I.R.; Bowman, A.R.; Pun, S.; Ma, Y.; Jee, W.S.S.; Bryer, H.P.; Epstein, S. Transforming growth factor-β administration modifies cyclosporine A-induced bone loss. Bone, 2001, 28, 583-588. (Pubitemid 32577375)
172. Centrella, M.; Massague, J.; Canalis, E. Human platelet-derived transforming growth factor-b stimulates parameters of bone growth in fetal rat calvaria. Endocrinology, 1986, 119, 2306-2312. (Pubitemid 17171418)
173. Noda, M.; Camilliere, J.J. In vivo stimulation of bone formation by transforming growth factor-b. Endocrinology, 1989, 124, 2991-2994. (Pubitemid 19154136)
174. Saraf, A.; Mikos, A.G. Gene delivery strategies for cartilage tissue engineering. Adv. Drug Deliv. Rev., 2006, 58, 592-603. (Pubitemid 43928174)
175. Kundu, B.; Khare, S.K.; Singh, G. Role of peptides in the treatment and diagnosis of osteoporosis. Peptides, 1999, 20, 523-537. (Pubitemid 29458998)
176. Kleinheinz, J.; Stratmann, U.; Joos, U.; Wiesmann, H.P. VEGF-activated angiogenesis during bone regeneration. J. Oral Maxillofac. Surg., 2005, 63, 1310-1316.
177. Sefcik, S.L.; Aronin, C.E.P.; Wieghaus, K.A.; Botchwey, E.A. Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineering. Biomaterials, 2008, 29, 2869-2877.
178. Kempen, D.H.R.; Lu, L.; Hefferan, T.E.; Creemers, L.B.; Maran, A.; Classic, K.L.; Dhert, W.J.A.; Yaszemski, M.J. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials, 2008, 29, 3245-3252.
179. Nie, H.; Wang, C.H. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J. Control. Release, 2007, 120, 111-121.
180. Kofron, M.D.; Laurencin, C.T. Bone tissue engineering by gene delivery. Adv. Drug Deliv. Rev., 2006, 58, 555-576. (Pubitemid 43928172)
181. Shen, H.C.; Peng, H.; Usas, A.; Gearhart, B.; Cummins, J.; Fu, F.H.; Huard, J. Ex vivo gene therapy-induced endochondral bone formation: comparison of muscle-derived stem cells and different subpopulations of primary muscle-derived cells. Bone, 2004, 34, 982-992. (Pubitemid 38749235)
182. Chung, C.; Burdick, J.A. Engineering cartilage tissue. Adv. Drug Deliv. Rev., 2008, 60, 243-262.
183. Sterodimas, A.; Faria, J.D.; Correa, W.E.; Pitanguy, I. Tissue engineering and auricular reconstruction: a review. J. Plast. Reconstr. Aesthet. Surg., doi:10.1016/j.bjps.2008.11.046.
184. Katsube, K.; Bishop, A.T.; Simari, R.D.; Ylä-Herttuala, S.; Friedrich, P.F. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J. Orthop. Res., 2005, 23, 469-474. (Pubitemid 40287877)
185. Malafayaa, P.B.; Silvaa, G.A.; Barana, E.T.; Reis, R.L. Drug delivery therapies II. Strategies for delivering bone regenerating factors. Curr. Opin. Solid State Mater. Sci., 2002, 6, 297-1212
186. Zhang, L.; Webster, T.J. Nanotechnology and nanomaterials: Promises for improved tissue regeneration. NanoToday, 2009, 4, 66-80.
187. Dawson, J.I.; Oreffo, R.O.C. Bridging the regeneration gap: Stem cells, biomaterials and clinical translation in bone tissue engineering, Archiv. Biochem. Biophys., 2008, 473, 124-131.
188. Kim, H.D.; Valentini, R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J. Biomed. Mater. Res., 2002, 59, 573-584.
189. Cooke, J.W.; Sarment, D.P.; Whitesman, L.A.; Miller, S.E.; Jin Q.; Lynch, S.E.; Giannobile, W.V. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng., 2006, 12, 1441-1450.
190. Zhang, W.; Frank, W.; Van Kuppevelt, X.T.H.; Daamen, W.F.; Bian, Z.; Jansen, J.A. The performance of human dental pulp stem cells on different three-dimensional scaffold materials. Biomaterials, 2006, 27, 5658-5668.
191. Wiedlocha, A.; Sorensen, V. Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr. Top. Microbiol. Immunol., 2004, 286, 45-79. (Pubitemid 38955147)
192. Morisada, T.; Kubota, Y.; Urano, T.; Suda, T.; Oike, Y. Angiopoietins and angiopoietin-like proteins in angiogenesis. Endothelium, 2006, 13, 71-79.
193. Wu, X.; Ma, J.; Han, J.D.; Wang, N.; Chen, Y.G. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. Microvasc. Res., 2006, 71, 12-19. (Pubitemid 43175844)
194. Losordo, D.W.; Dimmeler, S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Circulation, 2004, 109, 2487-2491. (Pubitemid 38720544)
195. Charwat, S.; Gyöngyösi, M.; Lang, I.; Graf, S.; Beran, G.; Hemetsberger, R.; Nyolczas, N.; Sochor, H.; Glogar, D. Role of adult bone marrow stem cells in the repair of ischemic myocardium: Current state of the art. Exp. Hematol., 2008, 36, 672-680.
196. DiMuzio, P.; Tulenko, T. Tissue engineering applications to vascular bypass graft development: The use of adipose-derived stem cells. J. Vascul. Surg., 2007, 45(6), A99-A103. (Pubitemid 46818870)
197. Grassl, E.D.; Oegema, T.R.; Tranquillo, R.T. Fibrin as an alternative biopolymer to type-I collagen for the fabrication of a media equivalent. J. Biomed. Mater. Res., 2002, 60 (4), 607-612.
198. Willerth, S.M.; Sakiyama-Elbert, S.E. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev., 2007, 59, 325-338. (Pubitemid 46879972)
199. Siegel, G.J.; Chauhan, N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev., 2000, 33 (2-3), 199-227. (Pubitemid 30697036)
200. Grill, R.; Murai, K.; Blesch, A.; Gage, F.H.; Tuszynski, M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci., 1997, 17(14), 5560-5572. (Pubitemid 27300320)
201. Vergara, C.; Ramirez, B. CNTF, a pleiotropic cytokine: emphasis on its myotrophic role. Brain Res. Brain Res. Rev., 2004, 47(1-3), 161-173.
202. Siegel, G.J.; Chauhan, N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev., 2000, 33(2-3), 199-227. (Pubitemid 30697036)
203. Rodríguez1, F.J.; Valero-Cabre, A.; Navarro, X. Regeneration and functional recovery following peripheral nerve injury. Drug Discov. Today, 2004, 1(2), 177-185. (Pubitemid 41123769)
204. Haile, Y.; Haastert, K.; Cesnulevicius, K.; Stummeyer, K.; Timmer, M.; Berski, S.; Dräger, G.; Gerardy-Schahn, R.; Grothe, C. Culturing of glial and neuronal cells on polysialic acid. Biomaterials, 2007, 28, 1163-1173. (Pubitemid 44816379)
205. Chewa, S.Y.; Mic, R.; Hokec, A.; Leong, K.W. The effect of the alignment of electrospun fibrous scaffolds on Schwann cell maturation. Biomaterials, 2008, 29, 653-661.
206. Tsuruma, A.; Tanaka, M.; Yamamoto, S.; Shimomur, M. Control of neural stem cell differentiation on honeycomb films. Colloids Surf. A, 2008, 313-314, 536-540
207. Liu, Y.; Suwa, F.; Wang, X.; Takemura, A.; Fang, Y.R.; Li, Y.; Zhao, Y.; Jin, Y. Reconstruction of a tissue-engineered skin containing melanocytes. Cell Biol. Int., 2007, 31, 985-990. (Pubitemid 46819069)
208. Bucala, R.; Spiegel, L.A.; Chesney, J.; Hogan, M.; Cerami, A. Circulating fibrocytes defines a new leukocyte subpopulation that mediates tissue repair. Mol. Med., 1994, 1(1), 71-81.
209. Hartlapp, I.; Abe, R.; Saeed, R.W.; Peng, T.; Voelter, W.; Bucala, R.; Metz, C.N. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo. FASEB J., 2001, 15(12), 2215-2224.
210. Abe, R.; Donnelly, S.C.; Peng, T.; Bucala, R.; Metz, C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J. Immunol., 2001, 166(12), 7556-7562.
211. Metcalfe, A.D.; Ferguson, M.W.J. Bioengineering skin using mechanisms of regeneration and repair. Biomaterials, 2007, 28, 5100-5113. (Pubitemid 47488488)
212. Kumbar, S.G.; Nukavarapu, S.P.; James, R.; Nair, L.S.; Laurencin, C.T. Electrospun poly (lactic acid-co-glycolic acid) scaffolds for skin tissue engineering. Biomaterials, 2008, 29, 4100-4107.
213. Kalbermatten, D.F.; Kingham, P.J.; Mahay, D.; Mantovani, C.; Pettersson, J.; Raffoul, W.; Balcin, H.; Pierer, G.; Terenghi, G. Fibrin matrix for suspension of regenerative cells in an artificial nerve conduit. J. Plast. Reconstr. Aesthet. Surg., 2008, 61, 669-675. (Pubitemid 351680445)
214. Harley, B.A.C.; Gibson, L.J. In vivo and in vitro applications of collagen-GAG scaffolds. Chem. Eng. J., 2008, 137, 102-121.
215. Boucard, N.; Viton, C.; Agay, D.; Mari, E.; Roger, T.; Chancerelle, Y.; Domar, A. The use of physical hydrogels of chitosan for skin regeneration following third-degree burns. Biomaterials, 2007, 28, 3478-3488.